Skip to main content
SpringerLink
Log in

Priority Groups Identification for the Development of Intensified Pharmacovigilance in Bogotá

  • Abstract
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Stephanie J Dancera, Consultant in Medical Microbiology.How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy.

  2. Gallelli L, Ferreri G, Colosimo M, et al. Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six-year retrospective study. Pharmacol Res. 2002 Nov; 46(5):395–400

    Article  PubMed  CAS  Google Scholar 

  3. Veehof LJ, Stewart RE, Meyboom-de Jong B, et al. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol. 1999 Sep; 55(7):533–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health District Secretariat, Bogotá D.C., Colombia

    A. Caro

Authors
  1. A. Caro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caro, A. Priority Groups Identification for the Development of Intensified Pharmacovigilance in Bogotá. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00009

Keywords

Search

Navigation